We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VLY:NASDAQValley National Bancorp Analysis

Data as of 2026-09-01 - not real-time

$13.64

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Valley National Bancorp is neutral at $13.64, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 7.0%. With RSI at 29.4 the momentum picture is oversold, alongside a bearish MACD signal. Price has been bracketed by support at $13.62 and resistance at $15.15.
Valuation screens as undervalued: a P/E of 11.6 sits below the sector average of 16.9. Analyst price targets sit 22.8% above the current price. Revenue is growing at 15.0% on a 34.5% profit margin. The 3.23% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 18.5%, a beta of 0.89 and a maximum drawdown of 14.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 8/10 conviction.

Top Market Events

Valley National Bancorp's stock has delivered a strong 62.Valley National Bancorp's stock has delivered a strong 62.Valley National Bancorp VLY reports robust financial results with significant loan growth and strategic use of AI to...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI at 29.4 signals oversold conditions
  • Trading above the 200-day average of 13.08
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • RSI at 29.4 signals oversold conditions
  • P/E of 11.6 versus sector average of 16.9
  • Trading above the 200-day average of 13.08

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 11.6 versus sector average of 16.9
  • Analyst targets imply +22.8% versus the current price
  • Profit margin of 34.5% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth15.00%
Profit Margin34.54%
P/E Ratio11.6
ROE8.95%
ROA1.07%
P/B Ratio1.0
Op. Cash Flow$575.0M
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI29.4
Support$13.62
Resistance$15.15
MA 20$14.47
MA 50$14.54
MA 200$13.08
MACDBearish
VolumeStable
Fear & Greed Index93.38

Valuation

Fair Value$12.81
Target Price$16.75
Upside/Downside22.80%
GradeUndervalued
TypeValue
Dividend Yield3.23%

Risk Assessment

Beta0.89
Volatility18.45%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.